Topic: Product Claims

Cognis Submitting Lutein Ester Dossier to EFSA
03/08/2010 - Cognis is submitting an article 13.5 dossier to the European Food Safety Authority (EFSA) with additional scientific evidence on the benefits of lutein esters on eye health. ...

FDA Finds POM Wonderful Less So
03/04/2010 - FDA issued an extensive warning letter to POM Wonderful regarding product claims on its Web site and product labeling, stating the company is making serious health claims that would position its products as unapproved new drugs. ...

NAD Asks Metabolic Research to Stop Stemulite Claims
03/03/2010 - The National Advertising Division (NAD) of the Council of Better Business Bureaus recommended Metabolic Research Inc., discontinue certain claims made for the company’s “Stemulite” dietary supplement ...

FTC Warns Kids’ Omega-3 Supplement Marketers
02/18/2010 - FTC sent letters last month to companies marketing various omega-3 fatty acid supplements cautioning that their product packaging and advertising might be in violation of the FTC Act unless they have scientific evidence to support claims that their products boost, improve, enhance, or support brain and vision function and development in children. ...

EU Lacks Consensus on Glucosamine Claims
02/16/2010 - BRUSSELS—European Union (EU) Member States continue to struggle to define the underlying criteria necessary to support health claim approval, as evidenced by their failure to agree on European Food Safety Authority’s (EFSA) recent unfavorable opinion on article 14 glucosamine claims. January deliberations in the Standing Committee, on the Food Chain and Animal Health Section on General Law did...

Industry Attorneys File Comments on FDA Supplement, Beverage Guidance
02/02/2010 - Ullman, Shapiro and Ullman filed comments with FDA regarding the agency’s draft guidance on factors distinguishing liquid dietary supplements from beverages. ...

Quten, NAD Hash Out Ad Claims
01/20/2010 - The National Advertising Division and Quten completed a review of the advertiser’s claims for Qunol CoQ10, with several claims being discontinued or modified, and one claim decision being appealed to the NARB. ...